Sphera Global Healthcare Fund, based in Tel Aviv, Israel, is a prominent fund management firm specializing in the healthcare sector. The firm primarily invests in Series B, Series C, and Series E rounds, as well as post-IPO equity, with a focus on both Israeli and U.S. markets. Sphera manages six distinct long/short equity strategies and one real estate private equity fund, leveraging a disciplined, fundamental investing approach overseen by a team of over twenty professionals.
Notable portfolio companies include aTyr Pharma, Deciphera Pharmaceuticals, Frontier Medicines, Immune-Onc Therapeutics, Outlook Therapeutics, and Werewolf Therapeutics. Sphera's investment philosophy emphasizes a repeatable process and deep sector expertise. The firm offers unique value-add services such as strategic guidance and operational support to its portfolio companies, ensuring they have the resources needed to succeed in the competitive healthcare landscape.
Sphera Global Healthcare Fund - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Top Investment Stages
Stage Mix
Sphera Global: A Tel Aviv-based fund management firm offering investment advice and portfolio services globally.
Concentration shown as share of disclosed investments by stage.
Sphera Funds Management
spherafund.com
Sectoral Asset Management
sectoral.com
Petrichor Healthcare Capital Management
petrichorcap.com
Sio Capital Management
siocapital.com
Sparta Group
spartagroupllc.com
Alive Israel Healthtech Fund
alivevc.com
Thyra Global Management
thyraglobal.com
Epiphron Capital
Octagon Capital Advisors
OrbiMed Advisors
orbimed.com
Rapha Capital Management
raphacap.com
Spindletop Capital
Sarissa Capital Management
sarissacap.com
Partner Fund Management
Ceiba Capital Management
